6 completed. 6 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
Follow amprenavir: new trials by email Literature Review of amprenavir trials Research Report on amprenavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of CNS-targeted HAART (CIT2) FDA Approved Antiretroviral Therapy (see list below) - HIV Infections | Phase 2 / Phase 3 | Completed | University of California, San Diego | 59 | 2007-03-01 | 2014-04-23 |
| Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor Amprenavir/ritonavir, Saquinavir/ritonavir - HIV Infections | Phase 2 / Phase 3 | Completed | Abbott | 16 | 2001-04-01 | 2006-07-28 |
| A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients Abacavir sulfate, Amprenavir, Lamivudine - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 1999-04-01 | 2005-06-24 | |
| Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors Amprenavir - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 210 | 2005-06-24 | |
| A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients Amprenavir, Lamivudine, Zidovudine - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 290 | 2005-06-24 | |
| A Comparison of 141W94 and Indinavir in HIV-Infected Patients Indinavir sulfate, Amprenavir - HIV Infections | Phase 3 | Completed | Glaxo Wellcome | 460 | 2005-06-24 |
HIV Infections (6) · AIDS Dementia Complex (1) · Cognitive Dysfunction (1) · Insulin Resistance (1)
Glaxo Wellcome (4) · Abbott (1) · University of California, San Diego (1)
United States (6) · Argentina (1) · Brazil (1) · Canada (1) · France (1) · Italy (1) · Poland (1) · Puerto Rico (1) · Spain (1) · United Kingdom (1)
Eugene Sun, M.D. (1) · M Dube (1) · Ronald J Ellis, MD, PhD (1)
R01MH058076 (1)